EUVIMEDOpdag EUVIMED
Systematische ÜbersichtOpen access · CC BY 4.0

A systematic review of literature on Insulin‐like growth factor‐2‐mediated hypoglycaemia in non‐islet cell tumours

Fateen Ata iD, Hassan Choudry, Adeel Ahmad Khan, Anum, Ibrahim Khamees, Anas Al-Sadi, Abdelaziz Mohamed, Lujain Malkawi, Esra'a Aljaloudi

Endocrinology, Diabetes & Metabolism · 2024

DOI: 10.1002/edm2.471 ↗

At a glance

Systematische Übersicht in Endocrinology, Diabetes & Metabolism, 2024. Written by Fateen Ata and 8 co-authors. Institution: Department of Endocrinology and Metabolism, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar. Major MEDLINE topics: Insulin-Like Growth Factor II, Hypoglycemia. Cited 19 times so far (Crossref); 29 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Insulin‐like growth factor‐2 (IGF‐2)‐mediated hypoglycemia is a rare yet clinically significant entity with considerable morbidity and mortality. Existing literature is limited and fails to offer a comprehensive understanding of its clinical trajectory, management and prognostication.

Methods

Systematic review of English‐language articles reporting primary patient data on IMH was searched using electronic databases (PubMed, Scopus and Embase) from any date up to 21 December 2022. Data were analysed in STATA‐16.

Results

The systematic review contains 172 studies, including 1 Randomised controlled trial, 1 prospective observational study, 5 retrospective observational studies, 150 case reports, 11 case series and 4 conference abstracts. A total of 233 patients were analysed, averaging 60.6 ± 17.1 years in age, with comparable proportions of males and females. The commonest tumours associated with Insulin‐like Growth Factor‐2‐mediated hypoglycaemia were fibrous tumours ( N = 124, 53.2%), followed by non‐fibrous tumours originating from the liver ( N = 21, 9%), hemangiopericytomas ( N = 20, 8.5%) and mesotheliomas ( N = 11, 4.7%). Hypoglycaemia was the presenting feature of NICT in 42% of cases. Predominant clinical features included loss of consciousness (26.7%) and confusion (21%). The mean IGF‐2 and IGF‐1 levels were 882.3 ± 630.6 ng/dL and 41.8 ± 47.8, respectively, with no significant correlation between these levels and patient outcomes. Surgical removal was the most employed treatment modality (47.2%), followed by medication therapy. The recovery rate was 77%, with chronic liver disease (CLD) significantly associated with a poor outcome (OR: 7.23, P: 0.03). Tumours originating from fibrous tissues were significantly associated with recovery ( p < .001). In the logistic regression model, CLD remained a significant predictor of poor outcomes.

Conclusion

This systematic review highlights that most non‐islet‐cell tumour‐hypoglycaemia (NICTH) is due to fibrous tumours. NICTs demonstrate a variable prognosis, which is fair if originating from fibrous tissue. Management such as octreotide, corticosteroids, diazoxide, embolization, radiotherapy and surgical resection have disparate success rates.

Subjects

MeSH terms (MEDLINE)

Insulin-Like Growth Factor IIHypoglycemiaMaleFemaleHumansInsulin-Like PeptidesRetrospective StudiesObservational Studies as Topic

Author keywords

IGF 2IGF IINICTHhypoglycaemiainsulin-like growth factor-2non-insulin mediated hypoglycaemianon-islet cell tumour hypoglycaemia

Substances

Insulin-Like Growth Factor IIInsulin-Like Peptides

Authors and institutions

  • Department of Endocrinology and Metabolism, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Internal Medicine, University Hospital of Coventry and Warwickshire (UHCW), Coventry, UK.
  • Department of Internal Medicine, Punjab Medical College/Faisalabad Medical University, Faisalabad, Pakistan.
  • Department of Internal Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.
  • Department of Internal Medicine, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Department of infectious diseases, University of Missouri-Kansas City, Missouri, USA.

ORCID profiles: Fateen Ata

Cite

APA

Ata, F., Choudry, H., Khan, A. A., Anum, Khamees, I., Al-Sadi, A., Mohamed, A., Malkawi, L., & Aljaloudi, E. (2024). A systematic review of literature on Insulin‐like growth factor‐2‐mediated hypoglycaemia in non‐islet cell tumours. Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.471

Vancouver

Ata F, Choudry H, Khan AA, Anum, Khamees I, Al-Sadi A, et al. A systematic review of literature on Insulin‐like growth factor‐2‐mediated hypoglycaemia in non‐islet cell tumours. Endocrinology, Diabetes & Metabolism. 2024. doi:10.1002/edm2.471

BibTeX
@article{Ata2024,
  author = {Ata, Fateen and Choudry, Hassan and Khan, Adeel Ahmad and Anum and Khamees, Ibrahim and Al-Sadi, Anas and Mohamed, Abdelaziz and Malkawi, Lujain and Aljaloudi, Esra'a},
  title = {A systematic review of literature on Insulin‐like growth factor‐2‐mediated hypoglycaemia in non‐islet cell tumours},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2024},
  doi = {10.1002/edm2.471}
}
Start for free →